Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.
Nanosonics Limited has announced the application for the quotation of 53,069 ordinary fully paid securities on the ASX. These securities are issued under an employee incentive scheme, reflecting the company’s ongoing efforts to incentivize and retain talent, which may enhance its operational capabilities and market position.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative products that help reduce the risk of infections in healthcare settings.
YTD Price Performance: 48.50%
Average Trading Volume: 792,347
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.36B
For an in-depth examination of NAN stock, go to TipRanks’ Overview page.